Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.8%

1 terminated/withdrawn out of 26 trials

Success Rate

96.2%

+9.6% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 25 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
10(100.0%)
10Total
N/A(10)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT02558738Completed

Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations

Role: lead

NCT01471184Not ApplicableCompleted

The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo

Role: lead

NCT01478152Not ApplicableCompleted

Effect of Ectoin® Inhalation Solution on Subjects With Mild Bronchial Asthma

Role: lead

NCT01684540Completed

Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis

Role: lead

NCT01684852Completed

Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution

Role: lead

NCT01225965Not ApplicableCompleted

Efficacy and Feasibility of Ectoin® Inhalation Solution in Inflammatory Obstruction and Ageing of the Lung

Role: lead

NCT02131038Completed

Application of Ectoine Nasal Spray in Comparison With Cromolyn Sodium Containing Nasal Spray in Patients With Allergic Rhinitis

Role: lead

NCT05699941Not ApplicableCompleted

Multicentre Post-market Study of Ectoin® Inhalation Solution in Treatment of Asthma.

Role: lead

NCT04910906Completed

Non-Interventional Multicentre Post-market Study of Ectoin® Vaginal Gel for Symptomatic Treatment of Vaginal Atrophy

Role: lead

NCT04203810Not ApplicableCompleted

Effectiveness and Tolerability of Ectoin® Mouth and Throat Spray Althaea Honey (ERS09)

Role: lead

NCT04021225Not ApplicableCompleted

Comparison of Ectoin® Containing Eye Drops and Ectoin® Containing Eye Spray With the Eye Spray Tears Again®

Role: lead

NCT04097327Completed

Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier Function

Role: lead

NCT03975257Not ApplicableCompleted

Ectoin Lozenges (EHT02) in the Treatment of Oropharyngeal Allergic Symptoms

Role: lead

NCT03932292Not ApplicableCompleted

Ectoin® Mouth Wash (EML03) in the Prevention and Treatment of Radiation-induced Oral Mucositis

Role: lead

NCT03943186Completed

Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.

Role: lead

NCT03693976Completed

Non-interventional Study With Ectoin Containing and/or Decongesting Nasal Spray in Patients With Rhinosinusitis

Role: lead

NCT02842372Withdrawn

Ectoin Dermatitis Cream 7% as First-line Therapy of Acute Skin Graft Versus Host Disease

Role: lead

NCT03480100Completed

Non-interventional Study of Ectoin Nasal Douche (END01) in Patients With Acute Viral Rhinosinusitis

Role: lead

NCT02816515Completed

Ectoin® Mouth Wash for the Prevention and Treatment of Chemotherapy-induced Oral Mucositis

Role: lead

NCT02632851Completed

Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution

Role: lead